Opinion
2021-1924 2021-2336
04-12-2023
UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. MYLAN TECHNOLOGIES INC., Defendant-Appellee UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Appellee UCB, INC., UCB PHARMA GMBH, LTS LOHMANN THERAPIE-SYSTEME AG, Plaintiffs-Appellants v. MYLAN TECHNOLOGIES INC., Defendant-Appellee
This order is nonprecedential.
ERRATA Filed Date: June 16, 2023
Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-00474-KAJ, Circuit Judge Kent A. Jordan.
Appeal from the United States District Court for the District of Vermont in No. 2:19-cv-00128-cr, Judge Christina Reiss.
ERRATA
Please make the following change to the caption in the opinion and judgment issued April 12, 2023, and the order granting an extension of time issued May 8, 2023:
The originating tribunal information has been corrected to state that Appeal No. 2021-2336 originated from the United States District Court for the District of Vermont.